drugset / Trial / NCT05531591

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)

NCT05531591

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to assess which antidepressants work the best in older adults who have treatment-resistant depression (TRD), and to test whether treatment-resistant late life depression is associated with declines in memory and attention and brain structure and function.

Timeline

Start
2019-08-01
Primary completion
2024-07-31
Completion
2024-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified 15 mg
Subject Bupropion Small molecule 300 mg
Subject Lithium Unknown 300 mg
Subject Nortriptyline Small molecule 1 mg/kg